Z-Asp (OMe) -Gln-Met-Asp (OMe) -FMK
Z-Asp (OMe) -Gln-Met-Asp (OMe) -FMK is an inhibitor for caspase-3, and inhibits Dihydroartemisinin and Dictamnine (HY-N0849) co-induced apoptosis[1].
Product Specifications
CAS Number
767287-99-0
UNSPSC
12352005
Target
Apoptosis; Caspase
Type
Reference compound
Related Pathways
Apoptosis
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/z-asp-ome-gln-met-asp-ome-fmk.html
Smiles
COC(C[C@@H](C(CF)=O)NC([C@H](CCSC)NC([C@H](CCC(N)=O)NC([C@H](CC(OC)=O)NC(OCC1=CC=CC=C1)=O)=O)=O)=O)=O
Molecular Formula
C29H40FN5O11S
Molecular Weight
685.72
References & Citations
[1]An FF, et al., Dihydroartemisinine enhances dictamnine-induced apoptosis via a caspase dependent pathway in human lung adenocarcinoma A549 cells. Asian Pac J Cancer Prev. 2013;14 (10) :5895-900.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740977-100 1x 100 µL
TGF-beta (1D11.16.8), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040226-500 1x 500 µL
Pmel17 / gp100 / SILV (NKI-beteb), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880646-100 1x 100 µL
Von Willebrand Factor (3E2D10 + VWF635), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details